Human viral superantigens: to be or not to be transactivated?
Lafon
Monique
M
Jouvin-Marche
Evelyne
E
Marche
Patrice N
PN
Perron
Hervé
H
D000956:Antigens, Viral / Q000235:genetics* / Q000276:immunology; D020077:Endogenous Retroviruses / Q000235:genetics* / Q000276:immunology; D018259:Herpesvirus 1, Human / Q000276:immunology; D004854:Herpesvirus 4, Human; D006801:Humans; D017874:Immediate-Early Proteins / Q000276:immunology; D019251:Nucleocapsid / Q000276:immunology; D019590:Nucleocapsid Proteins; D011820:Rabies virus / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology*; D018089:Superantigens / Q000235:genetics* / Q000276:immunology; D015533:Transcriptional Activation; D044767:Ubiquitin-Protein Ligases
D000956:Antigens, Viral; D017874:Immediate-Early Proteins; D019590:Nucleocapsid Proteins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens; C048925:herpes simplex virus, type 1 protein ICP4; C099601:nucleocapsid protein, Rabies virus; D044767:Ubiquitin-Protein Ligases; C051804:Vmw110 protein, Human herpesvirus 1